Author Affiliation: Expanded Programme on Immunization, Vaccines and Other Biologicals, Health Technology and Pharmaceuticals, World Health Organization, Geneva, Switzerland.
Meningococcal disease is among the most feared infections of children and young
adults because of the rapidity of onset, high mortality rate,
devastating sequelae, and tendency to spread and cause outbreaks. Two
articles in this issue of THE
JOURNAL1,2 highlight the challenge of serogroup
B meningococci—the most common cause of meningococcal disease in many
Wenger JD. Serogroup B Meningococcal DiseaseNew Outbreaks, New Strategies. JAMA. 1999;281(16):1541-1543. doi:10.1001/jama.281.16.1541